Reuters logo
BRIEF-Omeros presents late-stage trial data of eye drug at American Academy of Ophthalmology meeting
November 19, 2013 / 12:10 PM / in 4 years

BRIEF-Omeros presents late-stage trial data of eye drug at American Academy of Ophthalmology meeting

Nov 19 (Reuters) - Omeros Corp : * Reports phase 3 oms302 clinical data presented at the annual American academy

of ophthalmology meeting * Says in the clinical trials, oms302 reduced incidence of miosis * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below